- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Content analysis
?Positive | ||
Negative | ||
Uncertain | ||
Constraining | ||
Legalese | ||
Litigous | ||
Readability |
H.S. freshman Avg
|
- 10-K Annual report
- 3.1 Articles of Organization
- 4.12 Form of Common Stock Purchase Warrant
- 4.13 Registration Rights Agreement
- 10.5 Lease Relating to Certain Property In Waltham, Ma
- 10.43 Amendment No. 7 to License & Option Agreement with LG Life Sciences, LTD.
- 10.44 License, Supply Marketing Agreement with Menarini Int'l Operation Luxembourg
- 12.1 Statement Re: Computation of Ratios
- 21.1 Subsidiaries of the Registrant
- 23.1 Consent of Ernst & Young LLP
- 31.1 Consent of Chief Executive Officer Pursuant to Section 302
- 31.2 Consent of Chief Financial Officer Pursuant to Section 302
- 32.1 Consent of Chief Executive Officer Pursuant to Section 906
- 32.2 Consent of Chief Financial Officer Pursuant to Section 906
Exhibit 32.1
OSCIENT PHARMACEUTICALS CORPORATION
CERTIFICATION PURSUANT TO
18 U.S.C. SECTION 1350,
AS ADOPTED PURSUANT TO
SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002
In connection with the Annual Report of Oscient Pharmaceuticals Corporation (the “Company”) on Form 10-K for the fiscal year ended December 31, 2006 as filed with the Securities and Exchange Commission (the “Report”), I, Steven M. Rauscher, President and Chief Executive Officer of the Company, certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that:
1. The Report fully complies with the requirements of section 13(a) or 15(d) of the Securities Exchange Act of 1934; and
2. The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.
/s/ STEVEN M. RAUSCHER |
Steven M. Rauscher President & Chief Executive Officer |
Date: March 14, 2007